1,184
Views
27
CrossRef citations to date
0
Altmetric
Reviews

Prediction of volume of distribution at steady state in humans: comparison of different approaches

, , (Senior Pharmacologist, Office of Testing and Research) , (Director for Science, Office of Generic Drugs) & , PhD
Pages 855-872 | Published online: 17 May 2012

Bibliography

  • Schachter AD, Ramoni MF. Clinical forecasting in drug development. Nat Rev Drug Discov 2007;6(2):107-8
  • Yata N, Toyoda T, Murakami T, Phosphatidylserine as a determinant for the tissue distribution of weakly basic drugs in rats. Pharm Res 1990;7(10):1019-25
  • Reigner BG, Williams PE, Patel IH, An evaluation of the integration of pharmacokinetic and pharmacodynamic principles in clinical drug development. Experience within Hoffmann La Roche. Clin Pharmacokinet 1997;33(2):142-52
  • Wajima T, Fukumura K, Yano Y, Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: volume of distribution at steady state. J Pharm Pharmacol 2003;55(7):939-49
  • Wajima T, Yano Y, Fukumura K, Prediction of human pharmacokinetic profile in animal scale up based on normalizing time course profiles. J Pharm Sci 2004;93(7):1890-900
  • Ward KW, Smith BR. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time. Drug Metab Dispos 2004;32(6):612-19
  • Oie S, Tozer TN. Effect of altered plasma protein binding on apparent volume of distribution. J Pharm Sci 1979;68(9):1203-5
  • Jansson R, Bredberg U, Ashton M. Prediction of drug tissue to plasma concentration ratios using a measured volume of distribution in combination with lipophilicity. J Pharm Sci 2008;97(6):2324-39
  • Ghafourian T, Barzegar-Jalali M, Hakimiha N, Quantitative structure-pharmacokinetic relationship modelling: apparent volume of distribution. J Pharm Pharmacol 2004;56:339-50
  • Lombardo F, Obach RS, Dicapua FM, A hybrid mixture discriminant analysis-random forest computational model for the prediction of volume of distribution of drugs in human. J Med Chem 2006;49(7):2262-7
  • Poulin P, Theil FP. A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. J Pharm Sci 2000;89(1):16-35
  • Berezhkovskiy LM. Determination of volume of distribution at steady state with complete consideration of the kinetics of protein and tissue binding in linear pharmacokinetics. J Pharm Sci 2004;93(2):364-74
  • Rodgers T, Rowland M. Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. J Pharm Sci 2006;95(6):1238-57
  • Berry LM, Roberts J, Be X, Prediction of V(ss) from in vitro tissue-binding studies. Drug Metab Dispos 2010;38(1):115-21
  • Jones RD, Jones HM, Rowland M, PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution. J Pharm Sci 2011;100(10):4074-89
  • Graham H, Walker M, Jones O, Comparison of in-vivo and in-silico methods used for prediction of tissue: plasma partition coefficients in rat. J Pharm Pharmacol 2012;64(3):383-96
  • Payne MP, Kenny LC. Comparison of models for the estimation of biological partition coefficients. J Toxicol Environ Health A 2002;65(13):897-931
  • Caldwell GW, Masucci JA, Yan Z, Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data? Eur J Drug Metab Pharmacokinet 2004;29(2):133-43
  • Boxenbaum H. Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J Pharmacokinet Biopharm 1982;10(2):201-27
  • Obach RS, Baxter JG, Liston TE, The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. J Pharmacol Exp Ther 1997;283(1):46-58
  • Hosea NA, Collard WT, Cole S, Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches. J Clin Pharmacol 2009;49(5):513-33
  • Evans CA, Jolivette LJ, Nagilla R, Extrapolation of preclinical pharmacokinetics and molecular feature analysis of “discovery-like” molecules to predict human pharmacokinetics. Drug Metab Dispos 2006;34(7):1255-65
  • Bjorkman S. Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs. Br J Clin Pharmacol 2005;59(6):691-704
  • Sawada Y, Hanano M, Sugiyama Y, Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats. J Pharmacokinet Biopharm 1985;13(5):477-92
  • Rodgers T, Leahy D, Rowland M. Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. J Pharm Sci 2005;94(6):1259-76
  • Lombardo F, Obach RS, Shalaeva MY, Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data. J Med Chem 2002;45(13):2867-76
  • Lombardo F, Obach RS, Shalaeva MY, Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. J Med Chem 2004;47(5):1242-50
  • Bjorkman S, Wada DR, Berling BM, Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model. J Pharm Sci 2001;90(9):1226-41
  • Poulin P, Schoenlein K, Theil FP. Prediction of adipose tissue: plasma partition coefficients for structurally unrelated drugs. J Pharm Sci 2001;90(4):436-47
  • Poulin P, Theil FP. Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution. J Pharm Sci 2002;91(1):129-56
  • Berezhkovskiy LM. Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination. J Pharm Sci 2004;93(6):1628-40
  • Rodgers T, Rowland M. Mechanistic approaches to volume of distribution predictions: understanding the processes. Pharm Res 2007;24(5):918-33
  • Luttringer O, Theil FP, Poulin P, Physiologically based pharmacokinetic (PBPK) modeling of disposition of epiroprim in humans. J Pharm Sci 2003;92(10):1990-2007
  • Poulin P, Jones RD, Jones HM, PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach. J Pharm Sci 2011;100(10):4127-57
  • Bjorkman S. Prediction of the volume of distribution of a drug: which tissue-plasma partition coefficients are needed? J Pharm Pharmacol 2002;54(9):1237-45
  • Poulin P, Theil FP. Development of a novel method for predicting human volume of distribution at steady-state of basic drugs and comparative assessment with existing methods. J Pharm Sci 2009;98(12):4941-61
  • Poulin P, Ekins S, Theil FP. A hybrid approach to advancing quantitative prediction of tissue distribution of basic drugs in human. Toxicol Appl Pharmacol 2011;250(2):194-212
  • Berellini G, Springer C, Waters NJ, In silico prediction of volume of distribution in human using linear and nonlinear models on a 669 compound data set. J Med Chem 2009;52(14):4488-95
  • Gleeson MP, Waters NJ, Paine SW, In silico human and rat Vss quantitative structure-activity relationship models. J Med Chem 2006;49(6):1953-63
  • Berry LM, Li C, Zhao Z. Species differences in distribution and prediction of human V(ss) from preclinical data. Drug Metab Dispos 2011;39(11):2103-16
  • Mahmood I. Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development. Adv Drug Deliv Rev 2007;59(11):1177-92
  • Fagerholm U. Prediction of human pharmacokinetics–evaluation of methods for prediction of volume of distribution. J Pharm Pharmacol 2007;59(9):1181-90
  • Sui X, Sun J, Wu X, Predicting the volume of distribution of drugs in humans. Curr Drug Metab 2008;9(6):574-80
  • Fagerholm U. Prediction of human pharmacokinetics–gut-wall metabolism. J Pharm Pharmacol 2007;59(10):1335-43
  • Igari Y, Sugiyama Y, Sawada Y, Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model. J Pharmacokinet Biopharm 1983;11(6):577-93
  • Poulin P, Krishnan K, Salem H, Katz SA. Mechanistic animal-replacement approaches for predicting pharmacokinetics of organic chemicals. In: Toxicity Assessments Alternatives: Methods, Issues, Opportunities. Humana Press, Inc; Totowa: 1999
  • Jones HM, Parrott N, Jorga K, A novel strategy for physiologically based predictions of human pharmacokinetics. Clin Pharmacokinet 2006;45(5):511-42
  • De Buck SS, Sinha VK, Fenu LA, Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs. Drug Metab Dispos 2007;35(10):1766-80
  • Small H, Gardner I, Jones HM, Measurement of binding of basic drugs to acidic phospholipids using surface plasmon resonance and incorporation of the data into mechanistic tissue composition equations to predict steady-state volume of distribution. Drug Metab Dispos 2011;39(10):1789-93
  • Berezhkovskiy LM. On the accuracy of determination of unbound drug fraction in tissue using diluted tissue homogenate. J Pharm Sci 2012;101(5):1909-16
  • Poulin P, Haddad S. Advancing prediction of tissue distribution and volume of distribution of highly lipophilic compounds from a simplified tissue-composition-based model as a mechanistic animal alternative method. J Pharm Sci 2012; 101(6): 2250-61
  • Peyret T, Poulin P, Krishnan K. A unified algorithm for predicting partition coefficients for PBPK modeling of drugs and environmental chemicals. Toxicol Appl Pharmacol 2010;249(3):197-207
  • Poulin P, Haddad S. Microsome composition-based model as a mechanistic tool to predict nonspecific binding of drugs in liver microsomes. J Pharm Sci 2011;100(10):4501-17
  • Peyret T, Poulin P, Krishnan K. A unified algorithm for predicting partition coefficients for PBPK modeling of drugs and environmental chemicals. Toxicol Appl Pharmacol 2010;249(3):197-207
  • Kansy M, Senner F, Gubernator K. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J Med Chem 1998;41(7):1007-10
  • Valko KL, Nunhuck SB, Hill AP. Estimating unbound volume of distribution and tissue binding by in vitro HPLC-based human serum albumin and immobilised artificial membrane-binding measurements. J Pharm Sci 2011;100(3):849-62
  • Obach RS, Lombardo F, Waters NJ. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug Metab Dispos 2008;36(7):1385-405
  • Grover A, Benet LZ. Effects of drug transporters on volume of distribution. AAPS J 2009;11(2):250-61
  • Vauquelin G, Charlton SJ. Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action. Br J Pharmacol 2010;161(3):488-508
  • Kornhuber J, Henkel AW, Groemer TW, Lipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture system. J Cell Physiol 2010;224(1):152-64
  • Roberts MS, Magnusson BM, Burczynski FJ, Enterohepatic circulation: physiological, pharmacokinetic and clinical implications. Clin Pharmacokinet 2002;41(10):751-90
  • Fukuyama T, Yamaoka K, Ohata Y, A new analysis method for disposition kinetics of enterohepatic circulation of diclofenac in rats. Drug Metab Dispos 1994;22(3):479-85
  • Parrott N, Paquereau N, Coassolo P, An evaluation of the utility of physiologically based models of pharmacokinetics in early drug discovery. J Pharm Sci 2005;94(10):2327-43
  • Haddad S, Poulin P, Krishnan K. Relative lipid content as the sole mechanistic determinant of the adipose tissue:blood partition coefficients of highly lipophilic organic chemicals. Chemosphere 2000;40(8):839-43
  • DeJongh J, Verhaar HJ, Hermens JL. A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humans. Arch Toxicol 1997;72(1):17-25
  • Lukacova V PN, Lave T, Fraczkiewicz G, Role of fraction unbound in plasma in calculations of tissue: plasma partition coefficients. AAPS National Meeting; Atlanta, Georgia; 2008
  • Sawada Y, Hanano M, Sugiyama Y, Prediction of the volumes of distribution of basic drugs in humans based on data from animals. J Pharmacokinet Biopharm 1984;12(6):587-96

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.